YANKCOM Partnership’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$673K Buy
1,342
+133
+11% +$63.8K 0.24% 87
2026
Q1
$594K Buy
1,209
+93
+8% +$50.5K 0.24% 88
2025
Q4
$647K Buy
1,116
+61
+6% +$34.5K 0.28% 85
2025
Q3
$512K Buy
1,055
+106
+11% +$49.3K 0.23% 93
2025
Q2
$385K Buy
949
+171
+22% +$71.5K 0.19% 105
2025
Q1
$387K Buy
778
+13
+2% +$7.04K 0.21% 103
2024
Q4
$398K Buy
+765
New +$421K 0.21% 101

Other funds holding TMO

YANKCOM Partnership's TMO Position: Q2 2026 in Review

YANKCOM Partnership increased its Thermo Fisher Scientific (TMO) stake by 11% in Q2 2026, buying an estimated $63.8K and bringing the position to 1,342 shares worth $673K. The position accounts for 0.24% of the portfolio, ranked #87.

YANKCOM Partnership first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. 1,567 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • YANKCOM Partnership held 1,342 shares of Thermo Fisher Scientific worth $673K as of Q2 2026.
  • YANKCOM Partnership bought 133 Thermo Fisher Scientific shares in Q2 2026, an estimated $63.8K.
  • Thermo Fisher Scientific made up 0.24% of YANKCOM Partnership's portfolio in Q2 2026, its #87 holding.
  • YANKCOM Partnership first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • 1,567 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.